1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of FLCN mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of FLCN mRNA CTD PMID:22206623 1-benzylpiperazine increases expression ISO RGD:735088 6480464 N-benzylpiperazine results in increased expression of FLCN mRNA CTD PMID:26821219 14-Deoxy-11,12-didehydroandrographolide increases expression ISO RGD:1604509 6480464 14-deoxy-11, 12-didehydroandrographolide results in increased expression of FLCN mRNA CTD PMID:22101062 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:735088 6480464 Tetrachlorodibenzodioxin results in decreased expression of FLCN mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735088 6480464 Tetrachlorodibenzodioxin results in increased expression of FLCN mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FLCN mRNA CTD PMID:21570461 2,6-dinitrotoluene affects expression ISO RGD:735088 6480464 2, 6-dinitrotoluene affects the expression of FLCN mRNA CTD PMID:21346803 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of FLCN mRNA CTD PMID:25172293 4,4'-sulfonyldiphenol decreases methylation EXP 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of FLCN exon CTD PMID:33297965 acrylamide increases expression ISO RGD:1604509 6480464 Acrylamide results in increased expression of FLCN mRNA CTD PMID:32763439 aflatoxin B1 increases methylation ISO RGD:1604509 6480464 Aflatoxin B1 results in increased methylation of FLCN intron CTD PMID:30157460 Aflatoxin B2 alpha decreases methylation ISO RGD:1604509 6480464 aflatoxin B2 results in decreased methylation of FLCN intron CTD PMID:30157460 amiodarone increases expression ISO RGD:1604509 6480464 Amiodarone results in increased expression of FLCN mRNA CTD PMID:19774075 antirheumatic drug increases expression ISO RGD:1604509 6480464 Antirheumatic Agents results in increased expression of FLCN mRNA CTD PMID:24449571 aristolochic acid increases expression ISO RGD:1604509 6480464 aristolochic acid I results in increased expression of FLCN mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1604509 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FLCN mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1604509 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FLCN mRNA CTD PMID:32525701 benzo[b]fluoranthene increases expression EXP 6480464 benzo(b)fluoranthene results in increased expression of FLCN mRNA CTD PMID:26377693 benzo[e]pyrene decreases methylation ISO RGD:1604509 6480464 benzo(e)pyrene results in decreased methylation of FLCN intron CTD PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FLCN mRNA CTD PMID:21932408 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FLCN mRNA CTD PMID:33221593 bisphenol A increases expression ISO RGD:735088 6480464 bisphenol A results in increased expression of FLCN mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1604509 6480464 bisphenol A results in increased expression of FLCN mRNA CTD PMID:25047013 , PMID:29275510 bisphenol A multiple interactions ISO RGD:735088 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of FLCN mRNA CTD PMID:26496021 boron nitride increases expression ISO RGD:1604509 6480464 boron nitride results in increased expression of FLCN mRNA CTD PMID:30644070 bortezomib increases expression ISO RGD:1604509 6480464 Bortezomib results in increased expression of FLCN mRNA CTD PMID:20977926 buspirone increases expression ISO RGD:735088 6480464 Buspirone results in increased expression of FLCN mRNA CTD PMID:24136188 butanal increases expression ISO RGD:1604509 6480464 butyraldehyde results in increased expression of FLCN mRNA CTD PMID:26079696 carbamazepine affects expression ISO RGD:1604509 6480464 Carbamazepine affects the expression of FLCN mRNA CTD PMID:25979313 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of FLCN mRNA CTD PMID:17585979 copper atom multiple interactions ISO RGD:1604509 6480464 [Disulfiram binds to Copper] which results in decreased expression of FLCN mRNA CTD PMID:24690739 copper(0) multiple interactions ISO RGD:1604509 6480464 [Disulfiram binds to Copper] which results in decreased expression of FLCN mRNA CTD PMID:24690739 copper(II) sulfate increases expression ISO RGD:1604509 6480464 Copper Sulfate results in increased expression of FLCN mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:1604509 6480464 Coumestrol results in decreased expression of FLCN mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1604509 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FLCN mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1604509 6480464 Asbestos, Crocidolite results in increased expression of FLCN mRNA CTD PMID:18687144 crotonaldehyde increases expression ISO RGD:1604509 6480464 2-butenal results in increased expression of FLCN mRNA CTD PMID:20471460 cyclosporin A increases expression ISO RGD:1604509 6480464 Cyclosporine results in increased expression of FLCN mRNA CTD PMID:25562108 dioxygen increases expression ISO RGD:1604509 6480464 Oxygen deficiency results in increased expression of FLCN mRNA CTD PMID:17175027 disulfiram multiple interactions ISO RGD:1604509 6480464 [Disulfiram binds to Copper] which results in decreased expression of FLCN mRNA CTD PMID:24690739 diuron decreases expression ISO RGD:735088 6480464 Diuron results in decreased expression of FLCN mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1604509 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1604509 6480464 Doxorubicin results in decreased expression of FLCN mRNA CTD PMID:29803840 endosulfan increases expression ISO RGD:735088 6480464 Endosulfan results in increased expression of FLCN mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1604509 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FLCN mRNA CTD PMID:19167446 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of FLCN mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1604509 6480464 Ethyl Methanesulfonate results in increased expression of FLCN mRNA CTD PMID:23649840 folic acid decreases expression ISO RGD:1604509 6480464 Folic Acid results in decreased expression of FLCN mRNA CTD PMID:21867686 formaldehyde increases expression ISO RGD:1604509 6480464 Formaldehyde results in increased expression of FLCN mRNA CTD PMID:20655997 , PMID:23649840 gentamycin increases expression ISO RGD:735088 6480464 Gentamicins results in increased expression of FLCN mRNA CTD PMID:33387578 glafenine decreases expression ISO RGD:735088 6480464 Glafenine results in decreased expression of FLCN mRNA CTD PMID:24136188 hydrogen peroxide affects expression ISO RGD:1604509 6480464 Hydrogen Peroxide affects the expression of FLCN mRNA CTD PMID:20044591 leflunomide increases expression ISO RGD:735088 6480464 leflunomide results in increased expression of FLCN mRNA CTD PMID:24136188 manganese atom increases expression ISO RGD:1604509 6480464 Manganese results in increased expression of FLCN mRNA CTD PMID:17175027 manganese(0) increases expression ISO RGD:1604509 6480464 Manganese results in increased expression of FLCN mRNA CTD PMID:17175027 manganese(II) chloride increases expression ISO RGD:1604509 6480464 manganese chloride results in increased expression of FLCN mRNA CTD PMID:17175027 menadione affects expression ISO RGD:1604509 6480464 Vitamin K 3 affects the expression of FLCN mRNA CTD PMID:20044591 methapyrilene decreases methylation ISO RGD:1604509 6480464 Methapyrilene results in decreased methylation of FLCN intron CTD PMID:30157460 methyl methanesulfonate increases expression ISO RGD:1604509 6480464 Methyl Methanesulfonate results in increased expression of FLCN mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1604509 6480464 methylmercuric chloride results in increased expression of FLCN mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of FLCN mRNA CTD PMID:22776087 nefazodone increases expression ISO RGD:735088 6480464 nefazodone results in increased expression of FLCN mRNA CTD PMID:24136188 Octicizer multiple interactions EXP 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1, 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of FLCN mRNA CTD PMID:33367866 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of FLCN mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:735088 6480464 Acetaminophen results in increased expression of FLCN mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1604509 6480464 Acetaminophen results in increased expression of FLCN mRNA CTD PMID:22230336 pentanal increases expression ISO RGD:1604509 6480464 pentanal results in increased expression of FLCN mRNA CTD PMID:26079696 phenobarbital affects methylation EXP 6480464 Phenobarbital affects the methylation of FLCN gene CTD PMID:19233941 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of FLCN mRNA CTD PMID:23091169 phenobarbital affects expression ISO RGD:1604509 6480464 Phenobarbital affects the expression of FLCN mRNA CTD PMID:19159669 phenylmercury acetate multiple interactions ISO RGD:1604509 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FLCN mRNA CTD PMID:27188386 phorone affects expression ISO RGD:735088 6480464 phorone affects the expression of FLCN mRNA CTD PMID:18198479 pirinixic acid multiple interactions ISO RGD:1604509 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FLCN mRNA CTD PMID:19710929 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of FLCN mRNA CTD PMID:18445702 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of FLCN mRNA CTD PMID:28903501 propanal increases expression ISO RGD:1604509 6480464 propionaldehyde results in increased expression of FLCN mRNA CTD PMID:26079696 quercetin increases expression ISO RGD:1604509 6480464 Quercetin results in increased expression of FLCN mRNA CTD PMID:21632981 rotenone increases expression ISO RGD:735088 6480464 Rotenone results in increased expression of FLCN mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1604509 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1604509 6480464 Silicon Dioxide analog results in increased expression of FLCN mRNA CTD PMID:25895662 sodium arsenate multiple interactions ISO RGD:1604509 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FLCN mRNA CTD PMID:32525701 sunitinib increases expression ISO RGD:1604509 6480464 Sunitinib results in increased expression of FLCN mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:735088 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of FLCN mRNA CTD PMID:26496021 testosterone increases expression EXP 6480464 Testosterone deficiency results in increased expression of FLCN mRNA CTD PMID:33848595 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of FLCN mRNA CTD PMID:31919559 thimerosal multiple interactions ISO RGD:1604509 6480464 [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLCN mRNA CTD PMID:27188386 titanium dioxide affects expression EXP 6480464 titanium dioxide affects the expression of FLCN mRNA CTD PMID:17656681 tributyl phosphate multiple interactions EXP 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1, 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of FLCN mRNA CTD PMID:33367866 trichloroethene increases expression ISO RGD:735088 6480464 Trichloroethylene results in increased expression of FLCN mRNA CTD PMID:33387578 triphenyl phosphate multiple interactions EXP 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1, 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of FLCN mRNA CTD PMID:33367866 tris(2-butoxyethyl) phosphate multiple interactions EXP 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1, 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of FLCN mRNA CTD PMID:33367866 tris(2-chloroethyl) phosphate multiple interactions EXP 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1, 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of FLCN mRNA CTD PMID:33367866 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of FLCN mRNA CTD PMID:28973697 valdecoxib increases expression ISO RGD:735088 6480464 valdecoxib results in increased expression of FLCN mRNA CTD PMID:24136188 valproic acid increases methylation ISO RGD:1604509 6480464 Valproic Acid results in increased methylation of FLCN gene CTD PMID:29154799 vinclozolin increases expression ISO RGD:735088 6480464 vinclozolin results in increased expression of FLCN mRNA CTD PMID:22570695 vinclozolin increases methylation ISO RGD:735088 6480464 vinclozolin results in increased methylation of FLCN gene CTD PMID:31682807 vinclozolin decreases expression ISO RGD:735088 6480464 vinclozolin results in decreased expression of FLCN mRNA CTD PMID:23034163 zinc atom multiple interactions ISO RGD:1604509 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of FLCN mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1604509 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of FLCN mRNA CTD PMID:18593933